ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2020

Dec 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2020-12-17

Reporting Person: GIVEN DOUGLAS B (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-17	Common Stock	G	65	$0.00	Disposed	114673	Direct
2020-12-17	Common Stock	G	65	$0.00	Disposed	114608	Direct
2020-12-17	Common Stock	G	200	$0.00	Disposed	114408	Direct
2020-12-17	Common Stock	G	200	$0.00	Disposed	114208	Direct
2020-12-17	Common Stock	G	35	$0.00	Disposed	114173	Direct
2020-12-17	Common Stock	G	35	$0.00	Disposed	114138	Direct
2020-12-21	Common Stock	G	200	$0.00	Disposed	113938	Direct
2020-12-21	Common Stock	G	35	$0.00	Disposed	113903	Direct
2020-12-22	Common Stock	G	35	$0.00	Disposed	113868	Direct

Footnotes

F1: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.